Related references
Note: Only part of the references are listed.Agonist Effects of Propranolol on Non-Tumor Human Breast Cells
Lucia Gargiulo et al.
CELLS (2020)
The β-adrenergic receptor antagonist propranolol offsets resistance mechanisms to chemotherapeutics in diverse sarcoma subtypes: a pilot study
Letizia Porcelli et al.
SCIENTIFIC REPORTS (2020)
Effects of carbachol on apoptosis in human chronic myelogenous leukemic K562 cell line
Banu Aydin et al.
MARMARA MEDICAL JOURNAL (2019)
Investigation of the Roles of Non-neuronal Acetylcholine in Chronic Myeloid Leukemic Cells and their Erythroid or Megakaryocytic Differentiated Lines
Banu Aydin et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2018)
The Beta Adrenergic Receptor Blocker Propranolol Counteracts Retinal Dysfunction in a Mouse Model of Oxygen Induced Retinopathy: Restoring the Balance between Apoptosis and Autophagy
Maurizio Cammalleri et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2017)
2-adrenergic receptor activation promotes the proliferation of A549 lung cancer cells via the ERK1/2/CREB pathway
Ping Hu et al.
ONCOLOGY REPORTS (2016)
Propranolol induced G0/G1/S phase arrest and apoptosis in melanoma cells via AKT/MAPK pathway
Chengfang Zhou et al.
ONCOTARGET (2016)
A long-acting β2-adrenergic agonist increases the expression of muscarine cholinergic subtype-3 receptors by activating the β2-adrenoceptor cyclic adenosine monophosphate signaling pathway in airway smooth muscle cells
Yuan-Hua Liu et al.
MOLECULAR MEDICINE REPORTS (2015)
Antiproliferative effects of β-blockers on human colorectal cancer cells
M. Coelho et al.
ONCOLOGY REPORTS (2015)
Anti-tumor activity of the beta-adrenergic receptor antagonist propranolol in neuroblastoma
Jennifer K. Wolter et al.
ONCOTARGET (2014)
Cell Survival and Apoptosis Signaling as Therapeutic Target for Cancer: Marine Bioactive Compounds
Senthilkumar Kalimuthu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
The role of intracellular pathways in the proliferation of human K562 cells mediated by muscarinic receptors
Banu Aydin et al.
LEUKEMIA RESEARCH (2013)
OPINION Signalling bias in new drug discovery: detection, quantification and therapeutic impact
Terry Kenakin et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
Targeting of Beta Adrenergic Receptors Results in Therapeutic Efficacy against Models of Hemangioendothelioma and Angiosarcoma
Jessica M. Stiles et al.
PLOS ONE (2013)
The role of β-adrenergic receptor signaling in the proliferation of hemangioma-derived endothelial cells
Yi Ji et al.
CELL DIVISION (2013)
Involvement of a2-and ß2-adrenoceptors on breast cancer cell proliferation and tumour growth regulation
C. Perez Pinero et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Molecular Pathways: Beta-Adrenergic Signaling in Cancer
Steven W. Cole et al.
CLINICAL CANCER RESEARCH (2012)
Beta-adrenergic blocking drugs in breast cancer: a perspective review
Thomas I. Barron et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2012)
The beta 2-adrenergic receptor and Her2 comprise a positive feedback loop in human breast cancer cells
Ming Shi et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
β2-adrenoceptor blocker synergizes with gemcitabine to inhibit the proliferation of pancreatic cancer cells via apoptosis induction
Tao Shan et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2011)
β2-Adrenergic Receptor Agonists Inhibit the Proliferation of 1321N1 Astrocytoma Cells
L. Toll et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)
Regulation of M2, M3, and M4 muscarinic receptor expression in K562 chronic myelogenous leukemic cells by carbachol
Hulya Cabadak et al.
JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION (2011)
The Sympathetic Nervous System Induces a Metastatic Switch in Primary Breast Cancer
Erica K. Sloan et al.
CANCER RESEARCH (2010)
Adrenergic modulation of focal adhesion kinase protects human ovarian cancer cells from anoikis
Anil K. Sood et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
beta-Adrenergic Receptors in Cancer: Therapeutic Implications
Mario Perez-Sayans et al.
ONCOLOGY RESEARCH (2010)
Effects of propranolol in combination with radiation on apoptosis and survival of gastric cancer cells in vitro
Xinhua Liao et al.
RADIATION ONCOLOGY (2010)
Muscarinic receptors and ligands in cancer
Nirish Shah et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2009)
Inhibition of Pancreatic Cancer Cell Proliferation by Propranolol Occurs Through Apoptosis Induction The Study of beta-Adrenoceptor Antagonist's Anticancer Effect in Pancreatic Cancer Cell
Dong Zhang et al.
PANCREAS (2009)
Acetylcholine beyond neurons: the non-neuronal cholinergic system in humans
I. Wessler et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Basic and clinical aspects of non-neuronal acetylcholine: Expression of an independent, non-neuronal cholinergic system in lymphocytes and its clinical significance in immunotherapy
Takeshi Fujii et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2008)
Functional role of β-adrenergic receptors in the mitogenic action of nicotine on gastric cancer cells
Vivian Yvonne Shin et al.
TOXICOLOGICAL SCIENCES (2007)
Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma
Premal H. Thaker et al.
NATURE MEDICINE (2006)
Transduction of receptor signals by β-arrestins
RJ Leftowitz et al.
SCIENCE (2005)
Apoptosis pathways in cancer and cancer therapy
KM Debatin
CANCER IMMUNOLOGY IMMUNOTHERAPY (2004)
Comparative pharmacology of human β-adrenergic receptor subtypes -: characterization of stably transfected receptors in CHO cells
C Hoffmann et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2004)
Signalling of the M3-muscarinic receptor to the anti-apoptotic pathway
DC Budd et al.
BIOCHEMICAL JOURNAL (2004)
Localized effects of cAMP mediated by distinct routes of protein kinase A
K Tasken et al.
PHYSIOLOGICAL REVIEWS (2004)
Novel insights into muscarinic acetylcholine receptor function using gene targeting technology
J Wess
TRENDS IN PHARMACOLOGICAL SCIENCES (2003)
The C-terminal tail of the M3-muscarinic receptor possesses anti-apoptotic properties
DC Budd et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Mutations inducing divergent shifts of constitutive activity reveal different modes of binding among catecholamine analogues to the β2-adrenergic receptor
R Del Carmine et al.
BRITISH JOURNAL OF PHARMACOLOGY (2002)
Extraneuronal cholinergic system in lymphocytes
K Kawashima et al.
PHARMACOLOGY & THERAPEUTICS (2000)
beta-adrenoceptor signaling and its control of cell replication in MDA-MB-231 human breast cancer cells
TA Slotkin et al.
BREAST CANCER RESEARCH AND TREATMENT (2000)
Share Paper
